These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Didymin: an orally active citrus flavonoid for targeting neuroblastoma. Singhal SS; Singhal S; Singhal P; Singhal J; Horne D; Awasthi S Oncotarget; 2017 Apr; 8(17):29428-29441. PubMed ID: 28187004 [TBL] [Abstract][Full Text] [Related]
5. Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells. Wei J; Huang Q; Bai F; Lin J; Nie J; Lu S; Lu C; Huang R; Lu Z; Lin X Chem Biol Interact; 2017 Jan; 261():118-126. PubMed ID: 27899290 [TBL] [Abstract][Full Text] [Related]
6. Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein. Lin X; Bai F; Nie J; Lu S; Lu C; Zhu X; Wei J; Lu Z; Huang Q Cell Physiol Biochem; 2016; 40(6):1422-1432. PubMed ID: 27997902 [TBL] [Abstract][Full Text] [Related]
7. Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro. Burmakin M; Shi Y; Hedström E; Kogner P; Selivanova G Clin Cancer Res; 2013 Sep; 19(18):5092-103. PubMed ID: 23864164 [TBL] [Abstract][Full Text] [Related]
8. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis. Casalà C; Gil-Guiñón E; Ordóñez JL; Miguel-Queralt S; Rodríguez E; Galván P; Lavarino C; Munell F; de Alava E; Mora J; de Torres C Carcinogenesis; 2013 Feb; 34(2):268-76. PubMed ID: 23108190 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin. Gangoda L; Keerthikumar S; Fonseka P; Edgington LE; Ang CS; Ozcitti C; Bogyo M; Parker BS; Mathivanan S Oncotarget; 2015 May; 6(13):11175-90. PubMed ID: 25883214 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Valsesia-Wittmann S; Magdeleine M; Dupasquier S; Garin E; Jallas AC; Combaret V; Krause A; Leissner P; Puisieux A Cancer Cell; 2004 Dec; 6(6):625-30. PubMed ID: 15607966 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity. Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415 [TBL] [Abstract][Full Text] [Related]
12. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2. Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759 [TBL] [Abstract][Full Text] [Related]
13. Didymin, a dietary flavonoid glycoside from citrus fruits, induces Fas-mediated apoptotic pathway in human non-small-cell lung cancer cells in vitro and in vivo. Hung JY; Hsu YL; Ko YC; Tsai YM; Yang CJ; Huang MS; Kuo PL Lung Cancer; 2010 Jun; 68(3):366-74. PubMed ID: 19733932 [TBL] [Abstract][Full Text] [Related]
14. N-Myc knockdown and apigenin treatment controlled growth of malignant neuroblastoma cells having N-Myc amplification. Hossain MM; Banik NL; Ray SK Gene; 2013 Oct; 529(1):27-36. PubMed ID: 23941992 [TBL] [Abstract][Full Text] [Related]
15. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas. Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782 [TBL] [Abstract][Full Text] [Related]
16. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression. Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748 [TBL] [Abstract][Full Text] [Related]
17. The effect of EGB on proliferation of gastric carcinoma SGC7901 cells. Qian Y; Xia L; Shi W; Sun JJ; Sun YQ Clin Transl Oncol; 2016 May; 18(5):521-6. PubMed ID: 26489423 [TBL] [Abstract][Full Text] [Related]
18. p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance. Yogev O; Barker K; Sikka A; Almeida GS; Hallsworth A; Smith LM; Jamin Y; Ruddle R; Koers A; Webber HT; Raynaud FI; Popov S; Jones C; Petrie K; Robinson SP; Keun HC; Chesler L Cancer Res; 2016 May; 76(10):3025-35. PubMed ID: 27197232 [TBL] [Abstract][Full Text] [Related]
19. Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas. Zappasodi R; Cavanè A; Iorio MV; Tortoreto M; Guarnotta C; Ruggiero G; Piovan C; Magni M; Zaffaroni N; Tagliabue E; Croce CM; Zunino F; Gianni AM; Di Nicola M Int J Cancer; 2014 Nov; 135(9):2034-45. PubMed ID: 24648290 [TBL] [Abstract][Full Text] [Related]
20. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]